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SYMpoSIUM
Systems Biology: New Institute 
and Applications
Jieming Chen
Graduate School of Arts & Sciences, Yale University, New Haven, Connecticut
The Yale Systems Biology Institute (YSBI†) sponsored its first symposium at the univer-
sity’s West Campus in october 2010. The symposium served to provide Yale’s scientific
community with a glimpse into the wide range of research at the forefront of this interdisci-
plinary field. YSBI was conceived less than a year ago, and the event was the perfect forum
for its debut, both at Yale and in the U.S. scientific community. This article includes a brief
overview of the different topics presented at the symposium, followed by a discussion of the
advantages and challenges of practical application of systems biology.
Systems  biology  focuses  on  under-
standing and characterizing organizational
relationships and interactions of entities
within biological systems. This involves a
combination  of  disciplines,  including
physics, statistics, mathematics, engineer-
ing, and biology. The similarly interdisci-
plinary  Yale  Systems  Biology  Institute
(YSBI) was conceived less than one year
ago,  and  Günter  Wagner,  the  Alison
Richard Professor of Ecology and Evolu-
tionary Biology at Yale, was appointed the
chair of its Faculty Advisory Committee.
He describes systems biology as “an out-
growth of molecular biology. After taking
biology apart for so long, it is about time to
put things together again and study biolog-
ical systems as it should be, a whole.” Wag-
ner envisions the YSBI as a scientific re-
search hub at Yale, “to bring together fac-
ulties from across different departments,
particularly those with a keen interest in in-
terdisciplinary research.” He feels that sys-
tems biology can be pursued at three levels:
a) the macro-level, or the dynamics of the
biological systems of cells, tissues, and or-
gans, as opposed to conventional, static,
single-gene or single-protein snapshots of
biological processes; b) the micro-level, or
biological  interactions  at  the  molecular
level; and, most importantly, c) the devel-
opment  of  methodologies  and  research
tools. It is in these directions that Wagner is
guiding the YSBI.
The first YSBI symposium in October
2010 at Yale’s West Campus was divided
To whom all correspondence should be addressed: Jieming Chen, Graduate School of
Arts & Sciences, Yale University, New Haven, CT 06520; E-mail: jieming.chen@yale.edu.
†Abbreviations: YSBI, Yale Systems Biology Institute; ETH, Eidgen￶ssische Technische
Hochschule; GSMM, genome-scale metabolic model.into four thematic sessions. The first exam-
ined the logic processing, structure, and evo-
lution  of  gene  regulatory  networks  in
different species, a highly investigated area
of systems biology. The second segment was
more applications based, exploring the cou-
pling of high-throughput technology, such
as large-scale microarrays and next-genera-
tion sequencing, with synthetic biology and
computational modeling. Systems biology
has already been put to prognostic use to as-
sess tumor progression, analyze the interac-
tome in human diseases, and predict patient
outcomes. The third session examined sys-
tems  biology  approaches  to  elucidating
physiological functions, moving beyond the
fragmented  view  provided  by  traditional
molecular studies of specific physiological
components in isolation. Researchers specif-
ically discussed how current technology can
be used to quantitatively analyze the pro-
teome, the immune system, and the mam-
malian genome. Finally, the fourth and last
section highlighted synthetic biology and
molecular systems and advocated the engi-
neering and design of novel biological cir-
cuits derived from natural systems.
The symposium covered breadth with
considerable  depth  in  the  relatively  new
field of systems biology. It is imperative to
note that the idea of systems biology has a
relatively long history, with Ludwig von
Bertalanffy introducing his general systems
theory in 1928. However, the ideas have
only recently been institutionalized and pop-
ularized [1], primarily due to the maturation
of biotechnology, improved data availabil-
ity, and the promise of biomedical applica-
tions. As an emergent field, it is intriguing
that  systems  biology  is  already  showing
huge  practical  potential.  Speakers  Jorg
Stelling,  Professor  at  the  Department  of
Biosystems and Engineering at ETH Zurich,
and Jens Nielsen, Professor of Systems Bi-
ology at Chalmers University, Sweden, at-
tributed  the  cause  of  this  “hastened”
transition, from basic research to practical
applications, to synthetic biology.
Synthetic biology is the creation of non-
natural biological components or systems to
aid in the study of their natural counterparts
[2,3]. Hence, systems biology and synthetic
biology can be viewed as complementary.
The synthesis of new systems requires a
deep understanding of how biological net-
works  and  sub-cellular  components  are
wired. Conversely, analyses of natural sys-
tems enhance researchers’ capacity to create
novel systems. Stelling proposed applica-
tion-driven approaches to study biological
circuits,  as  opposed  to  a  conventional
knowledge-driven approach, which requires
detailed hypotheses, observations, and data
analyses.  Such  an  application-driven  ap-
proach tailors experiments to solve specific
problems. This extension from biology into
engineering expands the repertoire of scien-
tific tools and propels both fields forward
[4]. 
Stelling compared biological circuits to
electronics. While both generally behave ac-
cording to a set of “rules,” biological circuits
are often not as predictable as electrical cir-
cuits. Complexity and uncertainty constitute
the main challenges in designing biological
circuits. Complexity increases with size and
biological circuit dynamics. More specifi-
cally, biological circuits can adapt, mutate,
evolve, change, or have graded outcomes,
bestowing even more complexity. To inves-
tigate uncertainty and stochasticity in cell
signaling, Stelling’s group has developed
ensemble modeling [5,6]. This method en-
ables enumeration of the different configu-
rations  that  a  circuit  can  adopt  due  to
varying degrees of uncertainty. This config-
uration space also can be explored to reduce
prediction errors.
While Stelling designs models, he is
also interested in another arm of synthetic
biology that designs tools exclusively for en-
gineering biological components [7]. A very
prominent and influential example is the
Massachusetts Institute of Technology reg-
istry  of  Standard  Biological  Parts
(http://partsregistry.org),  a  repository  of
modularized  biological  components  that
provide standardized nomenclature for bio-
logical network construction.
Meanwhile, Nielsen focuses on com-
mercial applications. As a consultant for
several and founder of four biotechnology
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melded ideas from systems and synthetic bi-
ology  into  commercial  innovations.  His
group has developed cell factories for the
sustainable production of drugs, bio-fuels,
high-value bio-chemicals, and recombinant
proteins [8,9] and has improved the effi-
ciency of existing cell factories based on
yeast [10,11] and aspergilli [12]. Metabolic
engineering lies at the core of these innova-
tions. In systems biology, an organism’s me-
tabolism is represented by the evolutionarily
optimized network formed through the in-
teractions of genes and proteins. The effects
of the network can be manipulated by in-
serting new pathways and eliminating unde-
sirable ones. 
To try to achieve this, Nielsen imple-
mented a genome-scale metabolic model
(GSMM) of cell factories. Many modeling
techniques, such as physicochemical and ki-
netic ones, describe biological systems with
mathematical equations and strive to obtain
dynamic  predictions  of  each  component
through calculations. Consequently, bigger
models require a large number of parame-
ters to feed the equations. GSMM is advan-
tageous  because  it  is  a  constraint-based
model that uses a rule-based approach, im-
posing restrictions on its components to de-
rive a global outcome, without requiring
parameters. For example, to increase growth
factor production in an organism, positive
regulatory pathways in the metabolic net-
work must be enhanced while negative reg-
ulatory  pathways  are  simultaneously
suppressed. Different constraints are applied
until components achieving the desired ef-
fects are found by in silico analyses, fol-
lowed  by  experimental  verification.
Nielsen’s group has successfully induced
exogenous succinate production in Saccha-
romyces cerevisiae using this method. How-
ever, limitations in biological knowledge
hamper the extensive usage of the GSMM
approach. For instance, reconstruction of a
complete metabolic map requires a well-
characterized genome, as well as knowledge
of the link between gene and metabolic re-
action, both of which may be difficult to es-
tablish. 
In sum, the YSBI symposium covered
a  wide  spectrum  of  research,  increased
awareness of the field and its practical ap-
plications, and set the stage for the YSBI’s
debut. The latter is rapidly growing, having
just  recruited  two  new  faculty  members
from the Yale School of Medicine. As more
researchers join the ranks of the YSBI, more
collaboration will be fostered, pulling to-
gether Yale’s scientific community, while fu-
ture  symposia  will  help  to  encourage
collaboration beyond Yale as well.
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